An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum

An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum

NCT03137160 ·Status: COMPLETED ·Phase: PHASE2

A Randomized Study on Pemphigus Treatment With Humanized CD38 Antibody CM313.

NCT06663943 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

A Study to Evaluate the Efficacy, Safety, and Tolerability of Guselkumab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (HS)

NCT03628924 ·Status: COMPLETED ·Phase: PHASE2

Use of Infliximab for the Treatment of Pemphigus Vulgaris

NCT00283712 ·Status: COMPLETED ·Phase: PHASE2

Use of KC706 for the Treatment of Pemphigus Vulgaris

NCT00606749 ·Status: COMPLETED ·Phase: PHASE2

Gene Therapy for X-linked Chronic Granulomatous Disease (CGD) in Children

NCT00927134 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Topical Pentoxifylline Gel on Behcet's Disease Genital Ulcers

NCT04186559 ·Status: UNKNOWN ·Phase: PHASE2

Safety, Efficacy and PK/PD of QGE031 vs. Placebo in Patients With Active Bullous Pemphigoid Despite Oral Steroid Treatment

NCT01688882 ·Status: TERMINATED ·Phase: PHASE2

Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease

NCT07113743 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1/PHASE2

Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma Gangrenosum

NCT00690846 ·Status: WITHDRAWN ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid

NCT04206553 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Efficacy of Interleukin-2 Gargle in the Treatment of Oral Mucosa Lesion in Pemphigus Vulgaris

NCT04023149 ·Status: UNKNOWN ·Phase: PHASE2

Anti-IL-5 Therapy in Bullous Pemphigoid (BP)

NCT01705795 ·Status: COMPLETED ·Phase: PHASE2

A Study of Certolizumab Pegol to Evaluate Pharmacokinetics and Safety in Adult Healthy Chinese Subjects

NCT02365948 ·Status: COMPLETED ·Phase: PHASE1

A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses

NCT06136403 ·Status: RECRUITING ·Phase: PHASE2

Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus

NCT00483119 ·Status: TERMINATED ·Phase: PHASE2

Comparative Analysis of the Th17 Cellular Response in Active and Inactive Pemphigus Vulgaris Patients

NCT04096222 ·Status: UNKNOWN

Safety Study of PI-0824 to Treat Pemphigus Vulgaris

NCT00063752 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess Adverse Events and Change in Disease State in Adult Participants Being Treated With Humira in Participants Diagnosed With Pyoderma Gangrenosum (PG)

NCT04750213 ·Status: COMPLETED

Gene Therapy for Chronic Granulomatous Disease

NCT00394316 ·Status: TERMINATED ·Phase: EARLY_PHASE1

Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab.

NCT04084665 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1

Safety and Pharmacokinetics of Repeat Doses of CSL324 in Subjects With Hidradenitis Suppurativa and Palmoplantar Pustulosis

NCT03972280 ·Status: COMPLETED ·Phase: PHASE1

Study of Ruxolitinib in Sclerotic Chronic Graft-Versus-Host Disease After Failure of Systemic Glucocorticoids

NCT03616184 ·Status: COMPLETED ·Phase: PHASE2

Secukinumab for the Inflammatory Phase of Pyoderma Gangrenosum

NCT04274166 ·Status: WITHDRAWN ·Phase: PHASE2

A Study of PRN1008 in Adult Patients With Pemphigus Vulgaris

NCT02704429 ·Status: COMPLETED ·Phase: PHASE2